Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) is 25.40% higher on its value in year-to-date trading and has touched a low of $141.98 and a high of $263.73 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ALNY stock was last observed hovering at around $249.83 in the last trading session, with the day’s loss setting it -9.81%.
Currently trading at $240.02, the stock is 3.94% and 30.97% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.15 million and changing -3.93% at the moment leaves the stock 41.23% off its SMA200. ALNY registered 21.78% gain for a year compared to 6-month loss of 28.02%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 49.65% gain in the last 1 month and extending the period to 3 months gives it a 63.59%, and is -6.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.83% over the week and 3.85% over the month.
Alnylam Pharmaceuticals Inc (ALNY) has around 2100 employees, a market worth around $30.36B and $2.00B in sales. Profit margin for the company is -16.58%. Distance from 52-week low is 69.06% and -8.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.97%).
The EPS is expected to shrink by -0.17% this year
The shares outstanding are 125.79M, and float is at 125.76M with Short Float at 2.92%.
Alnylam Pharmaceuticals Inc (ALNY) Insider Activity
The most recent transaction is an insider sale by Greenstreet Yvonne, the company’s Chief Executive Officer. SEC filings show that Greenstreet Yvonne sold 7,093 shares of the company’s common stock on Jul 11 ’24 at a price of $261.00 per share for a total of $1.85 million. Following the sale, the insider now owns 73441.0 shares.
Alnylam Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 25 ’24 that SCHULMAN AMY W (Director) sold a total of 8,500 shares of the company’s common stock. The trade occurred on Jun 25 ’24 and was made at $240.00 per share for $2.04 million. Following the transaction, the insider now directly holds 8436.0 shares of the ALNY stock.
Still, SEC filings show that on Jun 25 ’24, Greenstreet Yvonne (Chief Executive Officer) disposed off 8,301 shares at an average price of $230.99 for $1.92 million. The insider now directly holds 80,534 shares of Alnylam Pharmaceuticals Inc (ALNY).
